569 related articles for article (PubMed ID: 30259550)
1. Neuroinflammation and blood-brain barrier disruption following traumatic brain injury: Pathophysiology and potential therapeutic targets.
Sulhan S; Lyon KA; Shapiro LA; Huang JH
J Neurosci Res; 2020 Jan; 98(1):19-28. PubMed ID: 30259550
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology Associated with Traumatic Brain Injury: Current Treatments and Potential Novel Therapeutics.
Pearn ML; Niesman IR; Egawa J; Sawada A; Almenar-Queralt A; Shah SB; Duckworth JL; Head BP
Cell Mol Neurobiol; 2017 May; 37(4):571-585. PubMed ID: 27383839
[TBL] [Abstract][Full Text] [Related]
3. Cerebral Edema in Traumatic Brain Injury: Pathophysiology and Prospective Therapeutic Targets.
Winkler EA; Minter D; Yue JK; Manley GT
Neurosurg Clin N Am; 2016 Oct; 27(4):473-88. PubMed ID: 27637397
[TBL] [Abstract][Full Text] [Related]
4. Delayed Administration of BQ788, an ET
Michinaga S; Kimura A; Hatanaka S; Minami S; Asano A; Ikushima Y; Matsui S; Toriyama Y; Fujii M; Koyama Y
J Neurotrauma; 2018 Jul; 35(13):1481-1494. PubMed ID: 29316834
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Blood-Brain Barrier Dysfunction in Traumatic Brain Injury.
Cash A; Theus MH
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397302
[TBL] [Abstract][Full Text] [Related]
6. A Mouse Controlled Cortical Impact Model of Traumatic Brain Injury for Studying Blood-Brain Barrier Dysfunctions.
Alluri H; Shaji CA; Davis ML; Tharakan B
Methods Mol Biol; 2018; 1717():37-52. PubMed ID: 29468582
[TBL] [Abstract][Full Text] [Related]
7. Adjudin Attenuates Cerebral Edema and Improves Neurological Function in Mice with Experimental Traumatic Brain Injury.
Liu YL; Yuan F; Yang DX; Xu ZM; Jing Y; Yang GY; Geng Z; Xia WL; Tian HL
J Neurotrauma; 2018 Dec; 35(23):2850-2860. PubMed ID: 29860924
[TBL] [Abstract][Full Text] [Related]
8. DHA Attenuates Cerebral Edema Following Traumatic Brain Injury via the Reduction in Blood-Brain Barrier Permeability.
Liu ZH; Chen NY; Tu PH; Wu CT; Chiu SC; Huang YC; Lim SN; Yip PK
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878052
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Pathophysiology of Traumatic Brain Injury.
Kaur P; Sharma S
Curr Neuropharmacol; 2018; 16(8):1224-1238. PubMed ID: 28606040
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiological Responses and Roles of Astrocytes in Traumatic Brain Injury.
Michinaga S; Koyama Y
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203960
[TBL] [Abstract][Full Text] [Related]
11. Mdivi-1 alleviates blood-brain barrier disruption and cell death in experimental traumatic brain injury by mitigating autophagy dysfunction and mitophagy activation.
Wu Q; Gao C; Wang H; Zhang X; Li Q; Gu Z; Shi X; Cui Y; Wang T; Chen X; Wang X; Luo C; Tao L
Int J Biochem Cell Biol; 2018 Jan; 94():44-55. PubMed ID: 29174311
[TBL] [Abstract][Full Text] [Related]
12. Neuroinflammation and Hypothalamo-Pituitary Dysfunction: Focus of Traumatic Brain Injury.
Mele C; Pingue V; Caputo M; Zavattaro M; Pagano L; Prodam F; Nardone A; Aimaretti G; Marzullo P
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799967
[TBL] [Abstract][Full Text] [Related]
13. Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood-brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study.
Lindblad C; Pin E; Just D; Al Nimer F; Nilsson P; Bellander BM; Svensson M; Piehl F; Thelin EP
Crit Care; 2021 Mar; 25(1):103. PubMed ID: 33712077
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology and treatment of cerebral edema in traumatic brain injury.
Jha RM; Kochanek PM; Simard JM
Neuropharmacology; 2019 Feb; 145(Pt B):230-246. PubMed ID: 30086289
[TBL] [Abstract][Full Text] [Related]
15. Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits.
Henry RJ; Ritzel RM; Barrett JP; Doran SJ; Jiao Y; Leach JB; Szeto GL; Wu J; Stoica BA; Faden AI; Loane DJ
J Neurosci; 2020 Apr; 40(14):2960-2974. PubMed ID: 32094203
[TBL] [Abstract][Full Text] [Related]
16. HMGB1 a-Box Reverses Brain Edema and Deterioration of Neurological Function in a Traumatic Brain Injury Mouse Model.
Yang L; Wang F; Yang L; Yuan Y; Chen Y; Zhang G; Fan Z
Cell Physiol Biochem; 2018; 46(6):2532-2542. PubMed ID: 29742510
[TBL] [Abstract][Full Text] [Related]
17. SIRT2 inhibition exacerbates neuroinflammation and blood-brain barrier disruption in experimental traumatic brain injury by enhancing NF-κB p65 acetylation and activation.
Yuan F; Xu ZM; Lu LY; Nie H; Ding J; Ying WH; Tian HL
J Neurochem; 2016 Feb; 136(3):581-93. PubMed ID: 26546505
[TBL] [Abstract][Full Text] [Related]
18. Tackling Neuroinflammation After Traumatic Brain Injury: Complement Inhibition as a Therapy for Secondary Injury.
van Erp IAM; Michailidou I; van Essen TA; van der Jagt M; Moojen W; Peul WC; Baas F; Fluiter K
Neurotherapeutics; 2023 Jan; 20(1):284-303. PubMed ID: 36222978
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 polyunsaturated fatty acid attenuates the inflammatory response by modulating microglia polarization through SIRT1-mediated deacetylation of the HMGB1/NF-κB pathway following experimental traumatic brain injury.
Chen X; Chen C; Fan S; Wu S; Yang F; Fang Z; Fu H; Li Y
J Neuroinflammation; 2018 Apr; 15(1):116. PubMed ID: 29678169
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
